November 27, 2021

News Science

The Science of News

First American dosed with Oxford-AstraZeneca phase three COVID-19 vaccine speaks out

1 min read

First American dosed with Oxford-AstraZeneca phase three COVID-19 vaccine speaks out

Oxford University, in partnership with AstraZeneca, started testing the first U.S. volunteers as part of its phase three COVID-19 vaccine trial. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS This Morning" with an exclusive interview with an American in the Oxford-AstraZeneca vaccine trial.

More News

News Science © 2005 Area.Control.Network™ All rights reserved.
All Rights Reserved © 2020 - 2021 Area Control Network (ACN)
The ACN News websites News.Science use Area Control Network TOS and Privacy Policies that you must agree to to use this site.
Privacy Policies & TOS